Robert W. Duggan - 11 Sep 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Robert W. Duggan
Issuer symbol
SMMT
Transactions as of
11 Sep 2024
Net transactions value
+$75,499,996
Form type
4
Filing time
13 Sep 2024, 18:25:05 UTC
Previous filing
09 Jul 2024
Next filing
13 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Award $75,499,996 +3,325,991 +0.61% $22.70 551,695,096 11 Sep 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person at a purchase price of $22.70 per share. The transaction closed on September 13, 2024.
F2 Excludes shares underlying options and warrants held by the Reporting Person.